Comment from Center on Reproductive Health, Law, and Policy
AnonymousSupportAcademic
Summary: A group of adolescent health researchers and clinicians argue that mifepristone is safe and effective for use by minors, citing clinical evidence and pharmacological data. They urge the FDA to ensure continued access to the medication without age-based restrictions or regulations.
We submit this comment to provide context on the safety and efficacy of mifepristone in minor adolescents.